SA
SAB Biotherapeutics, Inc. Warrant (SABSW)
NASDAQ·Technology·General
$0.00
—
Mkt Cap $357.48K
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$253.00
Range $171.60 – $297.00
Implied Upside
+14055455.6%
Consensus $253.00 vs current $0.00